Developing technology to quickly and efficiently bioprint human tissues at scale is the goal of a new project led by Penn State researchers.
Updated: Vaxcyte surges on Phase 1/2 data for 31-valent pneumococcal vaccine
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS